null

GenieFluor 488 Anti-Human CD29 Antibody [TS2/16.2.1] (AGEL0217)

SKU:
AGEL0217
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
Human
Host Species:
Mouse
Isotype:
IgG1
Clone:
TS2/16.2.1
Conjugation:
AF 488
Applications:
FC
€209 - €709
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

GenieFluor 488 Anti-Human CD29 Antibody [TS2/16.2.1]

The Human CD29 Monoclonal Antibody (Alexa Fluor 488 Conjugated) TS2/16 (AGEL0217) from Assay Genie is a cutting-edge tool designed for researchers studying CD29, a key cell surface protein involved in cell adhesion and migration. This monoclonal antibody, conjugated with the highly fluorescent Alexa Fluor 488, offers exceptional specificity and sensitivity in detecting CD29 in human samples.CD29, also known as integrin beta-1, plays a crucial role in cell-cell and cell-matrix interactions, making it a central player in processes like cell signaling, differentiation, and tissue morphogenesis. Its functions extend to various biological processes, including immune response modulation, wound healing, and cancer progression. As such, the Human CD29 Monoclonal Antibody is an invaluable tool for investigating the role of CD29 in diverse research areas such as immunology, developmental biology, and oncology.

The TS2/16 monoclonal antibody specifically targets CD29, enabling precise and reliable detection and quantification of this protein in different cell types and experimental settings. Its Alexa Fluor 488 conjugation further enhances its utility by providing bright, stable fluorescence for imaging and flow cytometry applications. Researchers can leverage this antibody to gain insights into the complex mechanisms involving CD29 and its impact on cellular behavior, offering new avenues for therapeutic development and disease understanding.Overall, the Human CD29 Monoclonal Antibody (Alexa Fluor 488 Conjugated) TS2/16 (AGEL0217) is a superior reagent that empowers researchers to delve deeper into the functional roles of CD29, paving the way for breakthrough discoveries in biomedical research and clinical applications.